Walmart Reaches Undisclosed Settlement In DOJ Opioid Dispensing Lawsuit
Walmart and the Justice Department confirmed they reached an undisclosed settlement Friday, August 28, 2026, resolving the department's December 2020 lawsuit over opioid dispensing at Walmart pharmacies.[1]
The 2020 suit accused Walmart pharmacies of filling thousands of invalid opioid prescriptions and failing to report suspicious orders in violation of the Controlled Substances Act.[1] The DOJ had cited potential civil penalties of $67,627 per unlawful prescription and $15,691 per unreported suspicious order, but the final settlement amount was not disclosed.[1]
Federal prosecutors in the Eastern District of Texas began examining the prescribing practices of doctors Howard Diamond and Randall Wade in summer 2016, and convictions of those doctors prompted scrutiny of Walmart pharmacies. The Texas office sought a criminal indictment of Walmart in 2018, but senior DOJ officials declined to pursue charges, so prosecutors filed a civil complaint in December 2020.
Walmart previously agreed to resolve separate opioid claims with states, localities and tribes for up to about $3.1 billion, with payments starting in 2023. Other pharmacy chains have also faced large federal enforcement actions, including a DOJ settlement with Walgreens for up to $350 million.
The mainstream summary does not mention the broader context of Walmart's previous opioid-related settlements, which total approximately $3.1 billion and are structured over six years beginning in 2023. This significant figure highlights Walmart's ongoing financial liability in relation to opioid dispensing practices, which is crucial for understanding the scale of the issue. Additionally, the summary overlooks the fact that other pharmacy chains, such as Walgreens, have faced similar allegations and settlements, with Walgreens agreeing to pay up to $350 million for unlawfully filling prescriptions and submitting false claims from 2012 to 2023. This comparison underscores a pattern of systemic issues within the pharmacy industry regarding opioid management and accountability.
Moreover, while the mainstream account focuses on the specific lawsuit against Walmart, it fails to address the larger implications of corporate practices contributing to the opioid epidemic. Studies indicate that the overpromotion of opioids and the complexities of supply chains have played significant roles in the crisis, with a one-unit increase in supply chain complexity linked to a 16% rise in opioid dispensing. This broader perspective reveals how systemic factors have compounded the public health crisis, which the summary does not explore.
Show source details & analysis (1 source)
📊 Relevant Data
Walmart previously settled opioid-related claims brought by states, localities, and tribes for up to approximately $3.1 billion, with payments structured over six years beginning in 2023.
Multistate Settlements Database — National Association of Attorneys General
Walgreens agreed to pay up to $350 million to resolve DOJ allegations that it illegally filled millions of invalid opioid prescriptions and submitted false claims to federal health programs from 2012 through 2023.
Walgreens Agrees To Pay Up to $350M for Illegally Filling Unlawful Opioid Prescriptions and Submitting False Claims — U.S. Department of Justice
The number of opioid prescriptions dispensed annually in the United States declined from a peak of over 255 million in 2012 to approximately 125 million in 2023.
Number of annual opioid prescriptions in the U.S. from 2006 to 2023 — Statista
📌 Key Facts
- On Friday, August 28, 2026, Walmart and DOJ confirmed a settlement resolving the department's December 2020 opioid dispensing lawsuit.
- The DOJ lawsuit alleged Walmart pharmacies filled thousands of invalid opioid prescriptions and failed to report suspicious orders, violating the Controlled Substances Act.
- Potential civil penalties cited by DOJ were $67,627 per unlawful prescription and $15,691 per unreported suspicious order, though the final settlement amount was not disclosed.
📰 Source Timeline (1)
Follow how coverage of this story developed over time